Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Zaramba Michael A
2. Date of Event Requiring Statement (Month/Day/Year)
10/17/2006
3. Issuer Name and Ticker or Trading Symbol
Stanley, Inc. [SXE]
(Last)
(First)
(Middle)
C/O STANLEY, INC., 3101 WILSON BOULEVARD, SUITE 700
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
SVP and Chief Strategy Officer
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

ARLINGTON, VA 22201
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 412,620 (1)
D
 
Common Stock 45,000 (2)
I
By Executive Deferred Compensation and Equity Incentive Trust

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Option to buy 07/01/2003 07/01/2008 Common Stock 9,000 $ 1.78 D  
Option to buy 07/01/2004 07/01/2009 Common Stock 9,000 $ 1.78 D  
Option to buy 07/01/2005 03/31/2010 Common Stock 9,000 $ 1.78 D  
Option to buy   (3) 04/29/2013 Common Stock 30,000 $ 2.35 D  
Option to buy   (4) 05/04/2014 Common Stock 30,000 $ 3.33 D  
Option to buy   (5) 05/04/2016 Common Stock 45,000 $ 7.86 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Zaramba Michael A
C/O STANLEY, INC.
3101 WILSON BOULEVARD, SUITE 700
ARLINGTON, VA 22201
      SVP and Chief Strategy Officer  

Signatures

By: /s/ Michael A. Zaramba 10/17/2006
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes 88,980 shares held in trust for Mr. Zaramba under the Stanley, Inc. Employee Stock Ownership Plan and 109,080 shares of unvested restricted stock which will vest upon completion of an initial public offering.
(2) Represents restricted stock held in the Executive Deferred Compensation and Equity Incentive Trust, of which 9,000 shares are vested and 36,000 shares are unvested. The unvested shares will vest upon completion of an initial public offering.
(3) Of the 30,000 options held, 18,000 are currently exercisable and 12,000 will vest upon completion of an initial public offering.
(4) Of the 30,000 options held, 12,000 are currently exercisable and 18,000 will vest upon completion of an initial public offering.
(5) These options vest over a five year period beginning on the date of grant, May 4, 2006, with a final vesting date of May 4, 2011. None are currently exercisable and none will vest upon completion of an initial public offering.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.